4.6 Article

Use and misuse of common terminology criteria for adverse events in cancer clinical trials

Related references

Note: Only part of the references are listed.
Article Oncology

Adverse Event Reporting in Cancer Clinical Trial Publications

Shanthi Sivendran et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Editorial Material Oncology

Enhancing Therapeutic Decision Making When Options Abound: Toxicities Matter

Nicole M. Kuderer et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Oncology

The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs

Saroj Niraula et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Review Oncology

Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis

Tracy Proverbs-Singh et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Review Oncology

Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review

Julien Peron et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Review Medicine, General & Internal

Treatment-Related Mortality With Bevacizumab in Cancer Patients A Meta-analysis

Vishal Ranpura et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Editorial Material Oncology

Is there room for improvement in adverse event reporting in the era of targeted therapies?

Maureen Edgerly et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Review Oncology

Patient-reported outcomes and the evolution of adverse event reporting in oncology

Andy Trotti et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)